A Day Up For Acrivon Therapeutics Inc.
Tue, Apr 09, 2024 at 07:22 PM
Acrivon Therapeutics Inc. (ACRV:NASDAQ) rocketted at $9.62, representing a gain of 62.8%. On Tue, Apr 09, 2024, ACRV:NASDAQ hit a New 2-Week High of $9.62. The stock got featured on our News Catalysts scanner on Tue, Apr 09, 2024 at 09:40 AM in the 'PRIVATE PLACEMENT' category. From Tue, Mar 26, 2024, the stock recorded 55.56% Up Days and 30.00% Green Days
About Acrivon Therapeutics Inc. (ACRV:NASDAQ)
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Company matches to patients whose tumors are predicted to be sensitive to each specific...
Top 10 Gainers:
- Scopus BioPharma Inc. (SCPS:NASDAQ), 212.5%
- Vinco Ventures Inc. (BBIG:NASDAQ), 200%
- Selina Hospitality PLC (SLNA:NASDAQ), 96.25%
- Laser Photonics Corporation (LASE:NASDAQ), 81.12%
- Mobile Global Esports Inc. (MGAM:NASDAQ), 77.78%
- two Class A (TWOA:NYSE), 71.47%
- Acrivon Therapeutics Inc. (ACRV:NASDAQ), 62.78%
- Calidi Biotherapeutics Inc. (CLDI:NYSEMKT), 62.39%
- Connexa Sports Technologies Inc. (CNXA:NASDAQ), 48.51%
- ICZOOM Group Inc. (IZM:NASDAQ), 43.45%